Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calmvalera Hevert EEG-based assessment in exam anxiety
2014-004840-36Phase 4Completed
- Sponsor
- Hevert-Arzneimittel
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Calmvalera Hevert in test anxiety and anxiety disorder, sponsored by Hevert-Arzneimittel. Primary endpoint: Primary outcome measures. Started May 2015; status: completed.
02
Drugs
Calmvalera Hevert
03
Conditions
test anxietyanxiety disorder
Beyond the preview
Go deeper on 2014-004840-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004840-36.